Mirati Therapeutics, Inc.

BANK OF AMERICA CORP /DE/

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

36,000

Value ($000)

2,115

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,115	0.0%	36,000	12/31/2023
2023 Q3	11/14/2023	16,908	0.0%	388,165	9/30/2023
2023 Q2	8/14/2023	11,842	0.0%	327,756	6/30/2023
2023 Q1	5/12/2023	14,361	0.0%	386,250	3/31/2023
2022 Q4	2/10/2023	13,734	0.0%	303,118	12/31/2022
2022 Q3	11/14/2022	18,221	0.0%	260,889	9/30/2022
2022 Q2	8/12/2022	12,181	0.0%	181,455	6/30/2022
2022 Q1	5/16/2022	14,762	0.0%	179,544	3/31/2022
2021 Q4	2/8/2022	10,434	0.0%	71,138	12/31/2021
2021 Q3	11/15/2021	20,697	0.0%	116,993	9/30/2021
2021 Q2	9/13/2021	35,089	0.0%	217,231	6/30/2021
2021 Q1	5/14/2021	25,417	0.0%	148,379	3/31/2021
2020 Q4	2/10/2021	20,520	0.0%	93,430	12/31/2020
2020 Q3	11/13/2020	16,286	0.0%	98,083	9/30/2020
2020 Q2	8/14/2020	16,977	0.0%	148,700	6/30/2020
2020 Q1	5/15/2020	11,459	0.0%	149,081	3/31/2020
2019 Q4	2/14/2020	6,061	0.0%	47,041	12/31/2019